Lakefront Biotherapeutics (GXEA) Q2 2026 Earnings Report
DE:GXEA Q2 2026 EPS Results
- Actual EPS
- EUR 0.03
- Consensus EPS
- -EUR 0.74
- Beat/Miss
- Beat by +EUR 0.77
- One Year Ago EPS
- -EUR 1.66
DE:GXEA Q2 2026 Revenue Results
- Actual Revenue
- EUR 12.59M
- Expected Revenue
- EUR 5.54M
- Beat/Miss
- Beat by +EUR 7.05M
- YoY Revenue Growth
- -80.97%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/10/2026
- Time
- After Close
- Conference Call
- Monday, August 10, 2026
DE:GXEA Upcoming Earnings
Lakefront Biotherapeutics's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GXEA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | -0.74- | -3.17 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -0.740.03 | -1.66 | 101.83% (+1.69) | |
| May 06, 2026 | 2026 (Q1) | -0.840.22 | -2.39 | 109.24% (+2.61) | |
| Feb 23, 2026 | 2025 (Q4) | -0.1112.43 | 0.27 | 4502.65% (+12.16) | |
| Nov 05, 2025 | 2025 (Q3) | -0.43-3.17 | -0.72 | -341.22% (-2.45) | |
| Jul 23, 2025 | 2025 (Q2) | -0.20-1.66 | 0.07 | -2475.64% (-1.73) | |
| Apr 23, 2025 | 2025 (Q1) | -0.13-2.39 | 0.35 | -788.92% (-2.74) | |
| Feb 12, 2025 | 2024 (Q4) | -0.490.27 | 2.31 | -88.32% (-2.04) | |
| Oct 30, 2024 | 2024 (Q3) | -0.15-0.72 | 0.37 | -291.65% (-1.09) | |
| Aug 01, 2024 | 2024 (Q2) | -0.070.07 | 0.08 | -11.36% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
